Pediatric heart transplantation in infants and small children under 3 years of age: Single center experience – "Early and long-term results".

We analyzed the early and long-term survival after ABO-compatible heart transplantation in children under 3 years of age from 1991 to 2021 at our center. This retrospective and descriptive study aimed to identify serious adverse events associated with mortality after pediatric heart transplantation. 46 patients with congenital heart failure (37%) in end-stage heart failure have undergone a pediatric heart transplantation. Primary outcome of interest was survival at follow-up time. Median (IQR) follow-up time (y), age (y), body-weight (kg) and BMI (kg/cm2) were 13.2 (5.7–19.5), 0.9 (0.2–2.0), 6.8 (4.3–10.0) and 14.2 (12.3–15.7). Twenty-four (52%) patients were male. 15 patients (33%) had a single ventricle physiology. At 30- days survival rate was 94 ± 4%. Survival rate at 1, 5, 10 and 15 years post HTx was 87 ± 5%, 84 ± 6%, 79 ± 6% and 63 ± 8%. One child underwent re-transplantation after 4 years, and another one after 11 years – in both cases due to graft failure. Higher early mortality in patients under 3 months of age and in patients with single ventricle physiology. Transplant free survival at 15 years was in children with cardiomyopathy better (71 ± 10%) than in those with congenital heart disease (50 ± 13%). One or more previous heart surgeries prior to HTx (n = 21) were associated to more mortality. Pediatric heart transplantation has acceptable long-term results and is still the best therapeutic option in children with end-stage cardiac failure. Underlying anomalies and single ventricle physiology, age below 3 months had a significant impact on survival. • First because, patients with congenital heart disease in end-stage heart failure have already undergone one or more previous heart operations. • Second, because of shortage suitable donors many patients need mechanically assist device support as bridge to transplantation. • Heart transplantation in infants and young children remains one of the majority challenges in pediatric cardiac surgery. • Our goal was to identify serious adverse events associated with mortality and graft failure after pediatric heart transplantation. [ABSTRACT FROM AUTHOR]